Pierre‐Yves Hatron

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

Christian Pagnoux, Alexandre Karras, C. Khouatra et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

Neurologic Manifestations in Primary Sjögren Syndrome

S. Delalande, J. de Sèze, A.L. Fauchais et al. · Medicine · 2004 · 641 citations

Rheumatology, Scleroderma, Sjögren’s Syndrome +14

Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output

Sophie Dupuis‐Girod, Isabelle Ginon, Jean‐Christophe Saurin et al. · JAMA · 2012 · 378 citations

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

I. Marie, É. Hachulla, Pierre‐Yves Hatron et al. · PubMed · 2001 · 288 citations

Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients

I. Marie, Pierre‐Yves Hatron, S. Dominique et al. · Arthritis & Rheumatism · 2011 · 285 citations · Full text